189 related articles for article (PubMed ID: 18829550)
41. Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
; Allaway R; Angus SP; Beauchamp RL; Blakeley JO; Bott M; Burns SS; Carlstedt A; Chang LS; Chen X; Clapp DW; Desouza PA; Erdin S; Fernandez-Valle C; Guinney J; Gusella JF; Haggarty SJ; Johnson GL; La Rosa S; Morrison H; Petrilli AM; Plotkin SR; Pratap A; Ramesh V; Sciaky N; Stemmer-Rachamimov A; Stuhlmiller TJ; Talkowski ME; Welling DB; Yates CW; Zawistowski JS; Zhao WN
PLoS One; 2018; 13(6):e0197350. PubMed ID: 29897904
[TBL] [Abstract][Full Text] [Related]
42. Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma.
Aoki H; Yokoyama T; Fujiwara K; Tari AM; Sawaya R; Suki D; Hess KR; Aldape KD; Kondo S; Kumar R; Kondo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6603-9. PubMed ID: 18006760
[TBL] [Abstract][Full Text] [Related]
43. miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways.
Saydam O; Senol O; Würdinger T; Mizrak A; Ozdener GB; Stemmer-Rachamimov AO; Yi M; Stephens RM; Krichevsky AM; Saydam N; Brenner GJ; Breakefield XO
Cancer Res; 2011 Feb; 71(3):852-61. PubMed ID: 21156648
[TBL] [Abstract][Full Text] [Related]
44. 14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly.
Somanath PR; Byzova TV
J Cell Physiol; 2009 Feb; 218(2):394-404. PubMed ID: 18853424
[TBL] [Abstract][Full Text] [Related]
45. Antagonistic actions of PAK1 and NF2/Merlin drive myelin membrane expansion in oligodendrocytes.
Baudouin L; Adès N; Kanté K; Bachelin C; Hmidan H; Deboux C; Panic R; Ben Messaoud R; Velut Y; Hamada S; Pionneau C; Duarte K; Poëa-Guyon S; Barnier JV; Nait Oumesmar B; Bouslama-Oueghlani L
Glia; 2024 Aug; 72(8):1518-1540. PubMed ID: 38794866
[TBL] [Abstract][Full Text] [Related]
46. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
[TBL] [Abstract][Full Text] [Related]
47. Role of the p21-activated kinases (PAKs) in influenza A virus replication.
Pascua PN; Lee JH; Song MS; Park SJ; Baek YH; Ann BH; Shin EY; Kim EG; Choi YK
Biochem Biophys Res Commun; 2011 Oct; 414(3):569-74. PubMed ID: 21982772
[TBL] [Abstract][Full Text] [Related]
48. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.
Ong CC; Jubb AM; Haverty PM; Zhou W; Tran V; Truong T; Turley H; O'Brien T; Vucic D; Harris AL; Belvin M; Friedman LS; Blackwood EM; Koeppen H; Hoeflich KP
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7177-82. PubMed ID: 21482786
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.
Reddy SD; Ohshiro K; Rayala SK; Kumar R
Cancer Res; 2008 Oct; 68(20):8195-200. PubMed ID: 18922890
[TBL] [Abstract][Full Text] [Related]
50. P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration.
Song B; Wang W; Zheng Y; Yang J; Xu Z
J Surg Res; 2015 Jun; 196(1):130-5. PubMed ID: 25791829
[TBL] [Abstract][Full Text] [Related]
51. Novel patient-derived xenograft and cell line models for therapeutic screening in NF2-associated schwannoma.
Zhao F; Chen Y; Li SW; Zhang J; Zhang S; Zhao XB; Yang ZJ; Wang B; He QY; Wang LM; Xu L; Liu PN
J Pathol; 2022 Aug; 257(5):620-634. PubMed ID: 35394061
[TBL] [Abstract][Full Text] [Related]
52. p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.
Qasim SL; Sierra L; Shuck R; Kurenbekova L; Patel TD; Rajapakshe K; Wulff J; Nakahata K; Kim HR; Landesman Y; Unger TJ; Coarfa C; Yustein JT
Oncogene; 2021 Feb; 40(6):1176-1190. PubMed ID: 33414491
[TBL] [Abstract][Full Text] [Related]
53. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
54. p21-Activated protein kinases and their emerging roles in glucose homeostasis.
Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E707-22. PubMed ID: 24368667
[TBL] [Abstract][Full Text] [Related]
55. Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.
Vasudevan HN; Payne E; Delley CL; John Liu S; Mirchia K; Sale MJ; Lastella S; Nunez MS; Lucas CG; Eaton CD; Casey-Clyde T; Magill ST; Chen WC; Braunstein SE; Perry A; Jacques L; Reddy AT; Pekmezci M; Abate AR; McCormick F; Raleigh DR
Nat Commun; 2024 Jan; 15(1):477. PubMed ID: 38216572
[TBL] [Abstract][Full Text] [Related]
56. RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions.
Cho JH; Park S; Kim S; Kang SM; Woo TG; Yoon MH; Lee H; Jeong M; Park YH; Kim H; Han YT; Suh YG; Kim BH; Kwon Y; Yun H; Park BJ
Mol Cancer Res; 2022 Mar; 20(3):412-424. PubMed ID: 34728553
[TBL] [Abstract][Full Text] [Related]
57. Plexiform schwannoma of the posterior pharyngeal wall in a patient with neurofibromatosis 2.
Raimondo L; Garzaro M; Mazibrada J; Pecorari G; Giordano C
Ear Nose Throat J; 2015 Mar; 94(3):E17-9. PubMed ID: 25738721
[TBL] [Abstract][Full Text] [Related]
58. Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.
Doddrell RD; Dun XP; Shivane A; Feltri ML; Wrabetz L; Wegner M; Sock E; Hanemann CO; Parkinson DB
Brain; 2013 Feb; 136(Pt 2):549-63. PubMed ID: 23413263
[TBL] [Abstract][Full Text] [Related]
59. Clinical Evaluation of P21 Activated Kinase 1 (PAK1) Activation in Gliomas and Its Effect on Cell Proliferation.
Venu A; Archana B; Kanumuri R; Vuttaradhi VK; D'Cruze L; Murugan S; Ganesh K; Prathiba D; Dymova MA; Rayala SK; Venkatraman G
Cancer Invest; 2021 Jan; 39(1):98-113. PubMed ID: 33251876
[TBL] [Abstract][Full Text] [Related]
60. Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity.
Maruta H
Phytother Res; 2014 May; 28(5):656-72. PubMed ID: 23943274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
